Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide for Insulin-Associated Weight Gain in T2DM
NCT01392898Phase 4Unknown
- Sponsor
- Radboud University Medical Center
- Start
- Feb 2012
- Primary completion
- May 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Radboud University Medical Center. Status: unknown.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01392898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01392898.